- $60.19m
- -$188.12m
- $52.30m
- 26
- 63
- 44
- 40
Annual cashflow statement for Metagenomi, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -21.4 | -43.6 | -68.3 | -78.1 |
| Depreciation | ||||
| Non-Cash Items | -0.943 | 2.1 | -0.932 | 23.2 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 46.3 | 69.5 | -26.4 | -59.7 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 24.3 | 29.7 | -91.4 | -109 |
| Capital Expenditures | -2.9 | -14 | -9.81 | -3.11 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -71.4 | -108 | 55.5 | -85 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -74.3 | -122 | 45.7 | -88.2 |
| Financing Cash Flow Items | — | — | -3.28 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 39.9 | 240 | 1.01 | 84 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -10.1 | 147 | -44.7 | -113 |